×
About 270 results

ALLMedicine™ Pleural Effusions Center

Research & Reviews  106 results

High Yield of Pleural Cell-Free DNA for Diagnosis of Oncogenic Mutations in Lung Adenoc...
https://doi.org/10.1016/j.chest.2023.01.019
Chest Mahmood K, Jampani P et. al.

Jan 25th, 2023 - Pleural cytology is currently used to assess targetable mutations in patients with advanced lung adenocarcinoma. However, it is fraught with low diagnostic yield. Can pleural cell-free DNA (cfDNA) be used to assess targetable mutations in lung ade...

Effect of chemotherapy, immunotherapy, and targeted therapies on removal of indwelling ...
https://doi.org/10.1016/j.rmed.2022.107093
Respiratory Medicine; Wang M, Sparrow K et. al.

Dec 23rd, 2022 - Indwelling pleural catheters (IPCs) are a mainstay therapy for malignant pleural effusions (MPEs). Many patients treated with IPCs achieve pleurodesis. We aimed to identify the effect of systemic therapies for non-small cell lung cancer (NSCLC) on...

Sensitivity and complications of thoracentesis and thoracoscopy: a meta-analysis.
https://doi.org/10.1183/16000617.0053-2022
European Respiratory Review : an Official Journal of the ... Martinez-Zayas G, Molina S et. al.

Dec 22nd, 2022 - Thoracentesis and thoracoscopy are used to diagnose malignant pleural effusions (MPE). Data on how sensitivity varies with tumour type is limited. Systematic review using PubMed was performed through August 2020 to determine the sensitivity of tho...

Impact of a Pleural Care Program on the Management of Patients With Malignant Pleural E...
https://doi.org/10.1097/LBR.0000000000000907
Journal of Bronchology & Interventional Pulmonology; Alwakeel AJ, Shieh B et. al.

Dec 9th, 2022 - Malignant pleural effusions (MPEs) are common and associated with a poor prognosis. Yet, many patients face suboptimal management characterized by repeated, nondefinitive therapeutic procedures and potentially avoidable hospital admissions. We con...

Indwelling pleural catheters for benign pleural effusions: a concise review.
https://doi.org/10.1097/MCP.0000000000000926
Current Opinion in Pulmonary Medicine; Matta A

Nov 8th, 2022 - Benign pleural effusions (BPEs) are more common than malignant effusions and their treatment involves treating the underlying disease process. However, in cases refractory to medical management, pleural interventions might be necessary. Use of ind...

see more →

Guidelines  1 results

ERS/EACTS statement on the management of malignant pleural effusions.
https://doi.org/10.1183/13993003.00349-2018
The European Respiratory Journal; Bibby AC, Dorn P et. al.

Jul 29th, 2018 - Malignant pleural effusions (MPE) are a common pathology, treated by respiratory physicians and thoracic surgeons alike. In recent years, several well-designed randomised clinical trials have been published that have changed the landscape of MPE m...

see more →

News  1 results

Cardiovascular Medicine and Surgery NetWork
https://www.mdedge.com/chestphysician/article/214641/society-news/cardiovascular-medicine-and-surgery-network/page/0/1?channel=28399

Jan 17th, 2020 - Clinical pulmonary medicine Definitive pleural interventions in malignant pleural effusions Malignant pleural effusions (MPEs) contribute significantly to symptom burden, and an emphasis on patient-centered outcomes prioritizes palliation of sympt.

see more →